Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 431-440 of 1772 for cancer

Edit search filters
  1. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  2. A Study To Evaluate Durvalumab Alone Or In Combination With Novel Agents In Subjects With NSCLC

    Scottsdale/Phoenix, AZ

  3. Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes

    Rochester, MN

  4. MUC1 Gene Expression

    Rochester, MN

  5. Low Dose Computed Tomography For Lung Cancer Screening

    Rochester, MN

  6. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer

    Rochester, MN

  7. Early Identification Of Chemotherapy Induced Cardiac Toxicity

    Rochester, MN

  8. Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma

    Rochester, MN

  9. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma

    Rochester, MN

  10. A Study Of The Safety And Effectiveness Of Methylene Blue MMX® Modified Release Tablets Administered To Subjects Undergoing Screening Or Surveillance Colonoscopy

    Rochester, MN

.

Mayo Clinic Footer